Sequoia Capital China

  • DATABASE (995)

  • ARTICLES (534)

    • DATABASE (995)
    • ARTICLES (534)
  • Sort by
    • Relevance
    • Date

Toutoushidao Capital was co-founded in 2015 by Cao Guoxiong, partner of Matrix Partners China, and Wu Xiaobo, a well-known financial writer. Mainly targeting the culture and entertainment sectors, it had planned to invest RMB 2bn–RMB 3bn in the next three years.

Founded in 2015, iResearch Capital is an investment fund of iResearch Group, one of the first consulting companies on internet research and analytics in China.  It focuses on investment in marketing, big data, corporate services and new media companies.

Co-Stone is one of the earliest venture capital firms in China, with about RMB 30 billion in assets under management today. It operates growth-stage investments and pre-IPO financings, focusing on TMT, biotechnology, consumer and services sectors in China. It has invested in more than 80 companies, where Co-Stone was the lead investor in over 60% of the financings.

ATM Capital is a China-based venture capital firm with a focus on Southeast Asia. In 2017, ATM Capital participated in the seed round of Indonesian coworking space operator Rework (now GoWork). Its its partners have invested in Go-Jek, Rocket Internet and several Chinese companies. It closed its US$200 million fund in January 2019. 

Healthcare-focused investment firm Vivo Capital was formed in 1996. Today it has over US$1.8 billion under management, making investments into private and public healthcare companies in the US and Greater China, as well as into promising early-stage innovative healthcare companies.

Kinzon Capital was co-founded by several former senior executives of Fosun Kinzon Capital (now called Fosun RZ Capital) in 2016. It invests primarily in early- and growth-stage TMT companies from China and the US. Kinzon Capital has offices in Beijing, Shanghai, Shenzhen and Silicon Valley and has invested RMB 2 billion in potential companies.

Formerly Fidelity Growth Partners, the renamed Eight Roads Ventures is the investment arm of Fidelity International Limited. In China for over 20 years, it counts among its successful investments/exits Alibaba, WuXi PharmaTech, AsiaInfo and iSoftStone. It focuses on early- and growth-stage companies across eight broad sectors.

Boyu Capital is a China-focused investment firm with offices in Beijing and Hong Kong. It manages tens of billions of US dollars and is one of the largest private equity investment firm in China, and mainly invests in sectors of consumer and retail, financial services, healthcare, media and technology.Boyu Capital was founded in 2011 by the late Ma Xuezheng (died in September 2019), former senior vice-president and financial director of Lenovo Group and managing director and partner of TPG, and Zhang Zixin (Louis Cheung), former general manager of Ping An Insurance. Boyu Capital's first chairman of the board was Jiang Zhicheng (Alvin Jiang), the grandson of former Chinese president Jiang Zemin.

Established in Shanghai in 2014, Wuqiong Venture Capital is an early-stage investment firm, having backed more than 10 startups in China including Beautysite, CeCelife and Orange-social.

Founded in 2015 by former vice president of Tencent and GM of Tencent M&A, Richard Peng (Peng Zhijian), and former vice GM of Tencent M&A, Kurt Xu, Genesis Capital specializes in growth stage investment of internet startups in China and the US.

Forebright Capital originates from the PE investment team established in 2001 under the state-owned China Everbright which is listed in Hong Kong. Everbright was spun off in May 2014 as an independent company. With money raised from institutional investors and family offices at home and abroad, Forebright Capital currently manages four US-dollar funds. It mainly invests in sectors of clean energy, healthcare and fintech.

Established in January 2015, Riverhead Capital Investment Management Co., Ltd. is among the first batch of insurance private equity fund pilot units approved by the China Insurance Regulatory Commission. With assets under management of RMB 17 billion, it mainly invests in medical, pharmaceutical, Internet, innovative financial services and other fields.

Centurium Capital is a private equity firm specializing in investments in the healthcare and consumer sectors in China. It was founded by David Li, Warburg Pincus's former Asia head, with a US$1.5 billion hard cap. It raised US$925 million in first close in June 2018. Centurium's limited partners include GIC, China Investment Corporation and Temasek Holdings. Centurium has cooperated with UCAR and Lepu Medical Technology to set up and manage two industrial M&A funds with initial funds of over RMB 6 billion.

Founded in 2012 by Wang Yawei, the former vice-president of China Asset Management and the founder of Top Ace Asset Management, Qianhe Capital provides asset management, equity investment and investment management services. As of April 2017, Qianhe Capital had RMB 24 billion under management and issued 11 trust plans and asset management plans.

Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China. 

Sorry, we couldn’t find any matches for“Sequoia Capital China”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.